Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1997 | 1 |
1999 | 2 |
2005 | 1 |
2009 | 1 |
2010 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Ondansetron, a 5-HT3 antagonist, improves cerebellar tremor.
J Neurol Neurosurg Psychiatry. 1997 Mar;62(3):282-4. doi: 10.1136/jnnp.62.3.282.
J Neurol Neurosurg Psychiatry. 1997.
PMID: 9069487
Free PMC article.
Clinical Trial.
Improving the convenience of home-based interferon beta-1a therapy for multiple sclerosis.
Lesaux J, Jadbäck G, Harraghy CE.
Lesaux J, et al.
J Neurosci Nurs. 1999 Jun;31(3):174-9. doi: 10.1097/01376517-199906000-00006.
J Neurosci Nurs. 1999.
PMID: 10846648
Item in Clipboard
Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS.
Reder AT, Ebers GC, Traboulsee A, Li D, Langdon D, Goodin DS, Bogumil T, Beckmann K, Konieczny A; Investigators of the 16-Year Long-Term Follow-Up Study.
Reder AT, et al.
Neurology. 2010 Jun 8;74(23):1877-85. doi: 10.1212/WNL.0b013e3181e240d0.
Neurology. 2010.
PMID: 20530324
Clinical Trial.
Item in Clipboard
A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis.
Wingerchuk DM, Lesaux J, Rice GP, Kremenchutzky M, Ebers GC.
Wingerchuk DM, et al. Among authors: lesaux j.
J Neurol Neurosurg Psychiatry. 2005 Sep;76(9):1294-6. doi: 10.1136/jnnp.2004.056499.
J Neurol Neurosurg Psychiatry. 2005.
PMID: 16107372
Free PMC article.
Clinical Trial.
Item in Clipboard
Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial.
Ebers GC, Traboulsee A, Li D, Langdon D, Reder AT, Goodin DS, Bogumil T, Beckmann K, Wolf C, Konieczny A; Investigators of the 16-year Long-Term Follow-Up Study.
Ebers GC, et al.
J Neurol Neurosurg Psychiatry. 2010 Aug;81(8):907-12. doi: 10.1136/jnnp.2009.204123. Epub 2010 Jun 19.
J Neurol Neurosurg Psychiatry. 2010.
PMID: 20562430
Clinical Trial.
Item in Clipboard
Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study.
Ebers GC, Reder AT, Traboulsee A, Li D, Langdon D, Goodin DS, Wolf C, Beckmann K, Konieczny A; Investigators of the 16-Year Long-Term Follow-Up Study.
Ebers GC, et al.
Clin Ther. 2009 Aug;31(8):1724-36. doi: 10.1016/j.clinthera.2009.08.003.
Clin Ther. 2009.
PMID: 19808131
Item in Clipboard
The evolution of neutralizing antibodies in multiple sclerosis patients treated with interferon beta-1b.
Rice GP, Paszner B, Oger J, Lesaux J, Paty D, Ebers G.
Rice GP, et al. Among authors: lesaux j.
Neurology. 1999 Apr 12;52(6):1277-9. doi: 10.1212/wnl.52.6.1277.
Neurology. 1999.
PMID: 10214759
Clinical Trial.
Item in Clipboard
Cite
Cite